AVE 50.0% 0.3¢ avecho biotechnology limited

marketing is the key to poh growth, page-33

  1. 5,792 Posts.
    lightbulb Created with Sketch. 735
    Yes, KC - I've heard 18 months, but will try to locate that source.

    Also, should be clarified, that not being cash flow positive can mean generating 8 million in revenue, but having 9 million in expenses.
    If they expect cash flow positive by say Oct 2012, it would mean that revenue sources would be at least $1 million a month by then, however if Oxy funding is thrown in and added to expenses, the monthly revenue expected would be much higher, as well as some possible license payments and milestone payments

    I expect POH to try and take oxy as far as possible themselves phase II/III and then auction it off to the highest bidder with the backing of 3M as the manufacturer +/- 3M as a bidder.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.